Methsuximide 150 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 150 mg

Reference Brands: Celontin (USA)

Category: Neurology

Methsuximide is a succinimide anticonvulsant that helps reduce abnormal electrical activity in the brain. It is prescribed for controlling absence seizures when other medications fail to provide adequate seizure control. The drug works by raising the seizure threshold and modulating neuronal firing. It is typically used under specialist guidance and requires monitoring due to potential side effects such as drowsiness, dizziness, and gastrointestinal discomfort.

Product Description:

Methsuximide is a succinimide anticonvulsant related to ethosuximide, and like it acts partly by reducing T-type calcium currents in thalamic neurons. Its active metabolite, N-desmethylmethsuximide, has a half-life of around forty hours and accounts for most of the effect. Unlike ethosuximide it has some activity against focal seizures as well as absences, which gives it a niche as an add-on in refractory epilepsy.

It is used for absence seizures that have not responded to other drugs, and occasionally in refractory focal epilepsy. Drowsiness, ataxia, dizziness and gastrointestinal upset are common. As with other succinimides, blood dyscrasias, drug-induced lupus and severe skin reactions have been reported, and blood counts should be checked periodically. It raises levels of phenytoin and phenobarbital, which can cause toxicity from the co-prescribed drug rather than from methsuximide itself.

Sourcing notes. Essentially a single-source US product with limited registration elsewhere, and it has been subject to supply interruptions. Buyers outside the US should expect named-patient import. The capsules are liquid-filled, which needs soft-gel or liquid-fill capability and narrows the potential manufacturer base. Demand is small and concentrated in specialist epilepsy centres, so any supply relationship depends on continuity more than price.